Cargando…

Developments in Burkitt’s lymphoma: novel cooperations in oncogenic MYC signaling

Burkitt’s lymphoma (BL) is an aggressive disorder associated with extremely high rates of cell proliferation tempered by high levels of apoptosis. Despite the high levels of cell death, the net effect is one of rapid tumor growth. The tumor arises within the germinal centers of secondary lymphoid ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spender, Lindsay C, Inman, Gareth J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890408/ https://www.ncbi.nlm.nih.gov/pubmed/24426788 http://dx.doi.org/10.2147/CMAR.S37745

Ejemplares similares

Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
por: Poole, Candace J., et al.
Publicado: (2018)

Inhibition of Germinal Centre Apoptotic Programmes by Epstein-Barr Virus
por: Spender, Lindsay C., et al.
Publicado: (2011)

Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation
por: De Falco, Giulia, et al.
Publicado: (2015)

MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas
por: Aquino, Gabriella, et al.
Publicado: (2013)

Targeting BRAF-mutant tumours with TGFBR1 inhibitors
por: Spender, Lindsay C, et al.
Publicado: (2017)

Deep Sequencing of MYC DNA-Binding Sites in Burkitt Lymphoma
por: Seitz, Volkhard, et al.
Publicado: (2011)

Alteration of MicroRNAs Regulated by c-Myc in Burkitt Lymphoma
por: Onnis, Anna, et al.
Publicado: (2010)

How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
por: Allday, Martin J.
Publicado: (2009)

Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases
por: Mundo, Lucia, et al.
Publicado: (2019)

Transforming Growth Factor-β Directly Induces p53-up-regulated Modulator of Apoptosis (PUMA) during the Rapid Induction of Apoptosis in Myc-driven B-cell Lymphomas
por: Spender, Lindsay C., et al.
Publicado: (2013)

The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS
por: Grygalewicz, Beata, et al.
Publicado: (2018)

Tuberous sclerosis complex is required for tumor maintenance in MYC‐driven Burkitt's lymphoma
por: Hartleben, Götz, et al.
Publicado: (2018)

Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature
por: Woroniecka, Renata, et al.
Publicado: (2022)

Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma
por: Kleo, Karsten, et al.
Publicado: (2019)

The CT-Element of The C-Myc Gene Does Not Predispose to Chromosomal Breakpoints in Burkitt'S Lymphoma
por: Weber, Achim, et al.
Publicado: (2006)

JNK/AP1 Pathway Regulates MYC Expression and BCR Signaling through Ig Enhancers in Burkitt Lymphoma Cells
por: Ding, Xiaoling, et al.
Publicado: (2020)

Epstein-Barr virus and Burkitt lymphoma
por: Rowe, Martin, et al.
Publicado: (2014)

Burkitt Lymphoma in the Mouse
por: Kovalchuk, Alexander L., et al.
Publicado: (2000)

Molecular mechanism of c‐Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma
por: Li, Ting, et al.
Publicado: (2020)

Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
por: Ayers, LW, et al.
Publicado: (2009)

MicroRNA-4728 serves as a suppressor and antagonist of oncogenic MAPK in Burkitt lymphoma
por: Wang, Wei, et al.
Publicado: (2018)

Burkitt Lymphoma of the Duodenum
por: Matsueda, Katsunori, et al.
Publicado: (2017)

Burkitt's lymphoma of the mandible
por: Kuo, Ying-Shiung, et al.
Publicado: (2017)

Burkitt Lymphoma: Pathogenesis and Immune Evasion
por: God, Jason M., et al.
Publicado: (2010)

Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for MYC and the MYC/IGH translocation
por: Vance, Gail H, et al.
Publicado: (2023)

Distinct genetic alterations in Burkitt-like lymphoma with 11q aberration and Burkitt lymphoma: a novel case report of composite lymphoma
por: Kim, Meejeong, et al.
Publicado: (2022)

Educational Case: Burkitt Lymphoma
por: Alexander, Caitlin J., et al.
Publicado: (2019)

Sporadic Burkitt Lymphoma of the Thoracic and Lumbar Spinal Canal in an Adult: Oncogenicity and a Literature Review
por: Srichawla, Bahadar S
Publicado: (2022)

Smac mimetics and TRAIL cooperate to induce MLKL-dependent necroptosis in Burkitt's lymphoma cell lines
por: Koch, Annkathrin, et al.
Publicado: (2021)

Clinical Aspects and Therapy of Sporadic Burkitt Lymphoma
por: Pagano, Livio, et al.
Publicado: (2009)

Seasonality of Burkitt's lymphoma in Uganda
por: Muwazi, L, et al.
Publicado: (2014)

Primary Gastric Burkitt’s Lymphoma
por: Mitra, Swarupa, et al.
Publicado: (2014)

Excretion of Immunoglobulins in Burkitt's Lymphoma
por: McFarlane, H., et al.
Publicado: (1970)

Pleural effusion in Burkitt's lymphoma.
por: Aderele, W. I., et al.
Publicado: (1975)

Cytology and Histochemistry of the Burkitt Lymphoma
por: Wright, D. H.
Publicado: (1963)

The next step for Burkitt lymphoma
por: Cho, Bin
Publicado: (2011)

Denis Burkitt and the African lymphoma
por: Magrath, I
Publicado: (2009)

Burkitts’s lymphoma – an atypical presentation
por: Ziade, Farah, et al.
Publicado: (2012)

Burkitt Lymphoma: beyond discoveries
por: Mbulaiteye, Sam M
Publicado: (2013)

Primary Gastric Burkitt’s lymphoma:
por: khan, Adnan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7ctllbqer1hlqumi16mdnf102b